Accessibility Menu

Luye Pharma Group(FRA) LUP

Market Cap€910.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€0.21
-8.70%
-0.02Today

Luye Pharma Group Financials at a Glance

Market Cap

€910.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

€0.02

P/E Ratio

11.57

Dividend

€0.00

Beta (Volatility)

-0.07 (Low)

Price

€0.21

Volume

0

Open

€0.21

Previous Close

€0.21

Daily Range

€0.21 - €0.21

52-Week Range

€0.19 - €0.43

Estimated Earnings Date

N/A

LUP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Luye Pharma Group

Luye Pharma Group Ltd. is an investment holding company, which engages in the developing, producing, marketing, and selling pharmaceutical products. It operates through the following segments: Oncology Drugs, Cardiovascular System Drugs, Alimentary Tract and Metabolism Drugs, and Others. The company was founded on June 8, 1994 and is headquartered in Yantai, China.

Industry

Pharmaceuticals

Sector

Health Care

Employees

5,221

CEO

Dian Bo Liu

Website

www.luye.cn

LUP Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

4.56%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

8.64%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€910.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

3.99B

Volume

0

Avg. Volume

436.152

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Luye Pharma Group Performance Analysis

Luye Pharma Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 845,229,54023.9%
20232023-12-31EUR 801,996,156-5.1%
20242024-12-31EUR 778,632,039-2.9%
20252025-12-31EUR 777,590,118-0.1%
Luye Pharma Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 0.02N/A
20232023-12-31EUR 0.02-24.4%
20242024-12-31EUR 0.02-13.4%
20252025-12-31EUR 0.0221.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

€910.75MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About LUP

What is the current price of Luye Pharma Group?

Luye Pharma Group is trading at €0.21 per share.

What is the 52-week range for Luye Pharma Group?

Over the past 52 weeks, Luye Pharma Group has traded between €0.19 and €0.43.

How much debt does Luye Pharma Group have?

As of the most recent reporting period, Luye Pharma Group reported total debt of €1.15B.

How much cash does Luye Pharma Group have on hand?

Luye Pharma Group reported €675.90M in cash and cash equivalents in its most recent financial results.

What is Luye Pharma Group’s dividend yield?

Luye Pharma Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services